Closed‐Loop Control of Macrophage Engineering Enabled by Focused‐Ultrasound Responsive Mechanoluminescence Nanoplatform for Precise Cancer Immunotherapy
Small · 2024
DOI: 10.1002/smll.202401398 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2024. Verfasst von Sixin Xu und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Physical Science and Technology, ShanghaiTech University, 393 Middle Huaxia Road, Shanghai, 201210, China. Hauptthemen laut MEDLINE: Macrophages, Immunotherapy, Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai Pujiang Program, Starting grant of ShanghaiTech University.
Abstract (Originalsprache)
Macrophage engineering has emerged as a promising approach for modulating the anti‐tumor immune response in cancer therapy. However, the spatiotemporal control and real‐time feedback of macrophage regulatory process is still challenging, leading to off‐targeting effect and delayed efficacy monitoring therefore raising risk of immune overactivation and serious side effects. Herein, a focused ultrasound responsive immunomodulator‐loaded optical nanoplatform (FUSION) is designed to achieve spatiotemporal control and status reporting of macrophage engineering in vivo. Under the stimulation of focused ultrasound (FUS), the immune agonist encapsulated in FUSION can be released to induce selective macrophage M1 phenotype differentiation at tumor site and the near‐infrared mechanoluminescence of FUSION is generated simultaneously to indicate the initiation of immune activation. Meanwhile, the persistent luminescence of FUSION is enhanced due to hydroxyl radical generation in the pro‐inflammatory M1 macrophages, which can report the effectiveness of macrophage regulation. Then, macrophages labeled with FUSION as a living immunotherapeutic agent (FUSION‐M) are utilized for tumor targeting and focused ultrasound activated, immune cell‐based cancer therapy. By combining the on‐demand activation and feedback to form a closed loop, the nanoplatform in this work holds promise in advancing the controllability of macrophage engineering and cancer immunotherapy for precision medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Physical Science and Technology, ShanghaiTech University, 393 Middle Huaxia Road, Shanghai, 201210, China.
- Department of Materials Science and Engineering, Stanford University, 496 Lomita Mall, Stanford, CA, 94305, USA.
- State Key Laboratory of Advanced Medical Materials and Devices, ShanghaiTech University, 393 Middle Huaxia Road, Shanghai, 201210, China.
- Shanghai Clinical Research and Trial Center, Shanghai, China.
ORCID-Profile: Xingjun Zhu
Förderung
- National Natural Science Foundation of China
- Shanghai Pujiang Program
- Starting grant of ShanghaiTech University
Zitieren
APA
Xu, S., Meng, L., Hu, Q., Li, F., Zhang, J., Kong, N., Xing, Z., Hong, G., & Zhu, X. (2024). Closed‐Loop Control of Macrophage Engineering Enabled by Focused‐Ultrasound Responsive Mechanoluminescence Nanoplatform for Precise Cancer Immunotherapy. Small. https://doi.org/10.1002/smll.202401398
Vancouver
Xu S, Meng L, Hu Q, Li F, Zhang J, Kong N, et al. Closed‐Loop Control of Macrophage Engineering Enabled by Focused‐Ultrasound Responsive Mechanoluminescence Nanoplatform for Precise Cancer Immunotherapy. Small. 2024. doi:10.1002/smll.202401398
BibTeX
@article{Xu2024,
author = {Xu, Sixin and Meng, Lingkai and Hu, Qian and Li, Fang and Zhang, Jieying and Kong, Na and Xing, Zhenyu and Hong, Guosong and Zhu, Xingjun},
title = {Closed‐Loop Control of Macrophage Engineering Enabled by Focused‐Ultrasound Responsive Mechanoluminescence Nanoplatform for Precise Cancer Immunotherapy},
journal = {Small},
year = {2024},
doi = {10.1002/smll.202401398}
}
EUVIMED